These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 20533865)

  • 1. Plasma concentrations of adipocyte fatty acid binding protein in patients with Cushing's syndrome.
    Ďurovcová V; Marek J; Hána V; Matoulek M; Zikán V; Haluzíková D; Kaválková P; Lacinová Z; Kršek M; Haluzík M
    Physiol Res; 2010; 59(6):963-971. PubMed ID: 20533865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome.
    Xu A; Wang Y; Xu JY; Stejskal D; Tam S; Zhang J; Wat NM; Wong WK; Lam KS
    Clin Chem; 2006 Mar; 52(3):405-13. PubMed ID: 16423904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma concentrations of fibroblast growth factors 21 and 19 in patients with Cushing's syndrome.
    Ďurovcová V; Marek J; Hána V; Matoulek M; Zikán V; Haluzíková D; Kaválková P; Lacinová Z; Krsek M; Haluzík M
    Physiol Res; 2010; 59(3):415-422. PubMed ID: 19681655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relations between serum adipocyte fatty acid-binding protein and type 2 diabetes in a community population].
    YE WH; PENG XH; AI YQ; CHEN H; ZHANG H; CAI DH
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Mar; 31(3):508-11. PubMed ID: 21421494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipocyte fatty acid-binding protein in obese children before and after weight loss.
    Reinehr T; Stoffel-Wagner B; Roth CL
    Metabolism; 2007 Dec; 56(12):1735-41. PubMed ID: 17998029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma adipocyte and epidermal fatty acid binding protein is reduced after weight loss in obesity.
    Haider DG; Schindler K; Bohdjalian A; Prager G; Luger A; Wolzt M; Ludvik B
    Diabetes Obes Metab; 2007 Sep; 9(5):761-3. PubMed ID: 17359244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of body fat reduction on plasma adipocyte fatty acid-binding protein concentration in obese patients with type 1 diabetes mellitus.
    Blaha V; Musil F; Smahelova A; Ticha A; Hyspler R; Haluzik M; Lesna J; Sobotka L
    Neuro Endocrinol Lett; 2012; 33 Suppl 2():6-12. PubMed ID: 23183502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating adipocyte fatty acid-binding protein, juvenile obesity, and metabolic syndrome.
    Krzystek-Korpacka M; Patryn E; Bednarz-Misa I; Mierzchala M; Hotowy K; Czapinska E; Kustrzeba-Wojcicka I; Gamian A; Noczynska A
    J Pediatr Endocrinol Metab; 2011; 24(11-12):921-8. PubMed ID: 22308843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different association of circulating levels of adipocyte and epidermal fatty acid-binding proteins with metabolic syndrome and coronary atherosclerosis in Chinese adults.
    Hong J; Gu W; Zhang Y; Yan Q; Dai M; Shi J; Zhai Y; Wang W; Li X; Ning G
    Atherosclerosis; 2011 Jul; 217(1):194-200. PubMed ID: 21492859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum adipocyte-fatty acid binding protein discriminates patients with permanent and temporary body weight loss.
    Stejskal D; Karpisek M; Bronsky J
    J Clin Lab Anal; 2008; 22(5):380-2. PubMed ID: 18803274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum AFBP levels are elevated in patients with nonalcoholic fatty liver disease.
    Suh JB; Kim SM; Cho GJ; Choi KM
    Scand J Gastroenterol; 2014 Aug; 49(8):979-85. PubMed ID: 24957697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study.
    Xu A; Tso AW; Cheung BM; Wang Y; Wat NM; Fong CH; Yeung DC; Janus ED; Sham PC; Lam KS
    Circulation; 2007 Mar; 115(12):1537-43. PubMed ID: 17389279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipocyte fatty acid-binding protein is associated with markers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in polycystic ovary syndrome women.
    Möhlig M; Weickert MO; Ghadamgadai E; Machlitt A; Pfüller B; Arafat AM; Pfeiffer AF; Schöfl C
    Eur J Endocrinol; 2007 Aug; 157(2):195-200. PubMed ID: 17656598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipocyte fatty acid binding protein in a Caucasian population: a new marker of metabolic syndrome?
    Stejskal D; Karpisek M
    Eur J Clin Invest; 2006 Sep; 36(9):621-5. PubMed ID: 16919044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weight loss in prepubertal obese children is associated with a decrease in adipocyte fatty-acid-binding protein without changes in lipocalin-2: a 2-year longitudinal study.
    Corripio R; Gónzalez-Clemente JM; Pérez-Sánchez J; Näf S; Gallart L; Nosàs R; Vendrell J; Caixàs A
    Eur J Endocrinol; 2010 Dec; 163(6):887-93. PubMed ID: 20870707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum adipocyte fatty acid-binding protein levels are associated with peripheral arterial disease in women, but not men, with type 2 diabetes mellitus.
    Ding M; Shi JY; Xing YZ; Sun B; Fang QH; Zhang JY; Zhang QM; Chen LM; Yu DM; Li CJ
    J Diabetes; 2018 Jun; 10(6):478-486. PubMed ID: 28303680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both fasting-induced leptin reduction and GH increase are blunted in Cushing's syndrome and in simple obesity.
    Grottoli S; Gauna C; Tassone F; Aimaretti G; Corneli G; Wu Z; Strasburger CJ; Dieguez C; Casanueva FF; Ghigo E; Maccario M
    Clin Endocrinol (Oxf); 2003 Feb; 58(2):220-8. PubMed ID: 12580939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zinc alpha-2 glycoprotein is overproduced in Cushing's syndrome.
    Escoté X; Aranda GB; Mora M; Casals G; Enseñat J; Vidal O; Esteban Y; Halperin I; Hanzu FA
    Endocrinol Diabetes Nutr; 2017 Jan; 64(1):26-33. PubMed ID: 28440767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of cortisol and ACTH responses to the desmopressin test in patients with Cushing's syndrome and simple obesity.
    Tsagarakis S; Vasiliou V; Kokkoris P; Stavropoulos G; Thalassinos N
    Clin Endocrinol (Oxf); 1999 Oct; 51(4):473-7. PubMed ID: 10583315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with atorvastatin reduces serum adipocyte-fatty acid binding protein value in patients with hyperlipidaemia.
    Karpisek M; Stejskal D; Kotolova H; Kollar P; Janoutova G; Ochmanova R; Cizek L; Horakova D; Yahia RB; Lichnovska R; Janout V
    Eur J Clin Invest; 2007 Aug; 37(8):637-42. PubMed ID: 17635574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.